Zacks Consensus Estimate of $1.19. The bottom line rose 9.1% year over year. Total revenues of $2.72 billion outperformed the ...

Cintas Corporation (Nasdaq: CTAS) today reported results for its fiscal 2026 first quarter ended August 31, 2025. Revenue for the first quarter of fiscal 2026 was $2.72 billion compared to $2.50 ...

Cintas Corporation reported strong Q1 results and raised guidance, but high valuation signals caution. Click here to read my ...

Good day, everyone, and welcome to the Cintas Corporation Announces Fiscal 2026 First Quarter Results Conference Call. Today's call is being recorded. At this time, I would like to turn the call over ...

Shares of Cintas Corp. CTAS shed 1.13% to $204.50 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.32% to 6,481.50 and Dow ...

CINCINNATI, September 10, 2025--(BUSINESS WIRE)--Cintas Corporation (Nasdaq: CTAS) today announced that it will release fiscal year 2026 first quarter results on Wednesday, September 24, 2025. The ...

Cintas on Wednesday raised its annual revenue and profit forecast on expectations that demand for its products such as rental uniforms and first-aid supplies will be resilient in the face of ...

Fantasy football rankings are ever-changing, and with the 2025 NFL season just hours away, the unfortunate truth is that there will be injuries, and those injuries will significantly impact rankings ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

ADDRESSING MISLEADING PRESCRIPTION DRUG ADVERTISEMENTS: Today, President Donald J. Trump signed a Presidential Memorandum to protect Americans by ensuring direct-to-consumer prescription drug ...